Management of the infant at increased risk for sepsis;La prise en charge du nourrisson plus vulnérable à la septicémie

Paediatrics and Child Health

Volumn 12, Issue 10, 2007, Pages 893-905

  Aziz, Khalid ^a   Barrington, Keith James ^b   Embree, Joanne E ^c   Kirpalani, Haresh M ^d   Lee, Shoo ^e   Sankaran, Koravangattu ^f   Whyte, Hilary E A ^g   Whyte, Robin K ^h   Farine, Dan ⁱ   Keegan, David ^j   McCourt, Catherine ^k   Solimano, Alfonso J ^l   Stark, Ann ^m   Premji, Shahirose ⁿ   Symington, Amanda ^d  

^a ROYAL ALEXANDRA HOSPITAL   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d MCMASTER CHILDREN S HOSPITAL   (Canada)

^e Capital Health Edmonton   (Canada)

^f ROYAL UNIVERSITY HOSPITAL   (Canada)

^g HOSPITAL FOR SICK CHILDREN   (Canada)

^h IWK HEALTH CENTRE   (Canada)

ⁱ MOUNT SINAI HOSPITAL   (Canada)

^j Public Agency of Canada ^*

^k PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^l BC CHILDREN S HOSPITAL   (Canada)

^m TEXAS CHILDREN S HOSPITAL   (United States)

ⁿ UNIVERSITY OF CALGARY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; GENTAMICIN; PENICILLIN G;

ANAPHYLAXIS; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BLOOD CELL COUNT; CHORIOAMNIONITIS; DIAGNOSTIC PROCEDURE; DISEASE TRANSMISSION; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION RISK; NEWBORN DEATH; NEWBORN SEPSIS; PREMATURE LABOR; PREMATURITY; PRENATAL DIAGNOSIS; REVIEW; STREPTOCOCCUS AGALACTIAE;

EID: 39649083107     PISSN: 12057088     EISSN: None     Source Type: Journal    
DOI: 10.1093/pch/12.10.893     Document Type: Review

References (33)

1. Baltimore RS, Huie SM, Meek JI, Schuchat A, O'Brien KL. Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics 2001;108:1094-8.
2. Zangwill KM, Schuchat A, Wenger JD. Group B streptococcal disease in the United States, 1990: Report from a multistate active surveillance system. MMWR 1992;41:25-32.
3. Davies H, LeBlanc J, Bortolussi R, McGeer A; PICNIC. The Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of neonatal group B streptococcal infections in Canada. Paediatr Child Health 1999;4:257-63.
4. Dahl MS, Tessin I, Trollfors B. Invasive group B streptococcal infections in Sweden: Incidence, predisposing factors and prognosis. Int J Infect Dis 2003;7:113-9.
5. Kalliola S, Vuopio-Varkila J, Takala AK, Eskola J. Neonatal group B streptococcal disease in Finland: A ten-year nationwide study. Pediatr Infect Dis J 1999;18:806-10.
6. Grimwood K, Darlow BA, Gosling IA, et al. Early-onset neonatal group B streptococcal infections in New Zealand 1998-1999. J Paediatr Child Health 2002;38:272-7.
7. Money DM, Dobson S; Society of Obstetricians and Gynaecologists of Canada. The prevention of early-onset neonatal group B streptococcal disease. J Obstet Gynaecol Can 2004;26:826-40.
8. Hafner E, Sterniste W, Rosen A, et al. Group B streptococci during pregnancy: A comparison of two screening and treatment protocols. Am J Obstet Gynecol 1998;179:677-81.
9. Embleton N, Wariyar U, Hey E. Mortality from early onset group B streptococcal infection in the United Kingdom. Arch Dis Child Fetal Neonatal Ed 1999;80:F139-41.
10. Royal College of Obstetricians and Gynaecologists. Prevention of early onset neonatal group B streptococcal disease (36) - November 2003. 〈http://www.rcog.org.uk/index.asp?PageID=520〉 (Version current at November 2, 2007).
11. Canadian Task Force on Preventive Health Care. Prevention of group B streptococcal infection in newborns: Recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ 2002;166:928-30.
12. Lannering B, Larsson LE, Rojas J, Stahlman MT. Early onset group B streptococcal disease. Seven year experience and clinical scoring system. Acta Paediatr Scand 1983;72:597-602.
13. Daley AJ, Isaacs D; Australasian Study Group for Neonatal Infections. Ten-year study on the effect of intrapartum antibiotic prophylaxis on early onset group B streptococcal and Escherichia coli neonatal sepsis in Australasia. Pediatr Infect Dis J 2004;23:630-4.
14. Puopolo KM, Madoff LC, Eichenwald EC. Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics 2005;115:1240-6.
15. Pinto NM, Soskolne EI, Pearlman MD, Faix RG. Neonatal early-onset group B streptococcal disease in the era of intrapartum chemoprophylaxis: Residual problems. J Perinatol 2003;23:265-71.
16. Fowlie PW, Schmidt B. Diagnostic tests for bacterial infection from birth to 90 days: A systematic review. Arch Dis Child Fetal Neonatal Ed 1998;78:F92-8.
17. Mtitimila EI, Cooke RW. Antibiotic regimens for suspected early neonatal sepsis. Cochrane Database Syst Rev 2004;(4)CD004495.
18. Kurlat I, Stoll BJ, McGowan JE Jr. Time to positivity for detection of bacteremia in neonates. J Clin Microbiol 1989;27:1068-71.
19. Boyer KM, Gadzala CA, Kelly PD, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. III. Interruption of mother-to-infant transmission. J Infect Dis 1983;148:810-6.
20. Boyer KM, Gotoff SR Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986;314:1665-9.
21. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002;51(RR-11):1-22.
22. Bromberger P, Lawrence JM, Braun D, Saunders B, Contreras R, Petitti DB. The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants. Pediatrics 2000;106:244-50.
23. Ottolini MC, Lundgren K, Mirkinson LJ, Cason S, Ottolini MG. Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn. Pediatr Infect Dis J 2003;22:430-4.
24. Rodwell RL, Leslie AL, Tudehope DI. Early diagnosis of neonatal sepsis using a hematologic scoring system. J Pediatr 1988;112:761-7.
25. Schelonka RL, Yoder BA, Hall RB, et al. Differentiation of segmented and band neutrophils during the early newborn period. J Pediatr 1995;127:298-300.
26. Schrag SJ, Zell ER, Lynfield R, et al; Active Bacterial Core Surveillance Team. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002;347:233-9.
27. Towers CV, Suriano K, Asrat T. The capture rate of at-risk term newborns for early-onset group B streptococcal sepsis determined by a risk factor approach. Am J Obstet Gynecol 1999;181(5 Pt 1):1243-9.
28. Benitz WE, Gould JB, Druzin ML. Antimicrobial prevention of early-onset group B streptococcal sepsis: Estimates of risk reduction based on a critical literature review. Pediatrics 1999;103:e78.
29. Smulian JC, Bhandari V, Vintzileos AM, et al. Intrapartum fever at term: Serum and histologic markers of inflammation. Am J Obstet Gynecol 2003;188:269-74.
30. Lieberman E, Lang JM, Frigoletto F Jr, Richardson DK, Ringer SA, Cohen A. Epidural analgesia, intrapartum fever, and neonatal sepsis evaluation. Pediatrics 1997;99:415-9.
31. Escobar GJ, Li DK, Armstrong MA, et al. Neonatal sepsis workups in infants >/=2000 grams at birth: A population-based study. Pediatrics 2000;106:256-63.
32. Alexander JM, McIntire DM, Leveno KJ. Chorioamnionitis and the prognosis for term infants. Obstet Gynecol 1999;94:274-8.
33. Jackson GL, Engle WD, Sendelbach DM, et al. Are complete blood cell counts useful in the evaluation of asymptomatic neonates exposed to suspected chorioamnionitis? Pediatrics 2004;113:1173-80.